Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (XENE) will release its Q4 and full year 2023 financial results on February 29, 2024, after the U.S. financial markets close. A conference call/webcast will follow at 4:30 pm Eastern Time. Investors can access the live webcast on Xenon's website.

VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its fourth quarter and full year 2023 financial and operating results after the close of U.S. financial markets on Thursday, February 29, 2024.

Conference Call/Webcast Information:

Date:		Thursday, February 29, 2024
Time:		4:30 pm Eastern Time (1:30 pm Pacific Time)
Dial-In:		(800) 715-9871 or (646) 307-1963 for international callers
Conference ID:		9376408

A live audio webcast will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com 

FAQ

When will Xenon Pharmaceuticals Inc. (XENE) report its Q4 and full year 2023 financial results?

Xenon Pharmaceuticals Inc. (XENE) will report its Q4 and full year 2023 financial results on February 29, 2024, after the close of U.S. financial markets.

What time will the conference call/webcast be held for Xenon Pharmaceuticals Inc. (XENE)?

The conference call/webcast for Xenon Pharmaceuticals Inc. (XENE) will be held at 4:30 pm Eastern Time on February 29, 2024.

How can investors access the live audio webcast for Xenon Pharmaceuticals Inc. (XENE)?

Investors can access the live audio webcast on the 'Investors' section of Xenon's website.

What is the conference ID for Xenon Pharmaceuticals Inc. (XENE) conference call/webcast?

The conference ID for Xenon Pharmaceuticals Inc. (XENE) conference call/webcast is 9376408.

Are the listed dates and times for Xenon Pharmaceuticals Inc. (XENE) subject to change?

Yes, the listed dates and times for Xenon Pharmaceuticals Inc. (XENE) are subject to change.